IL6 and diabetes mellitus: The chronic low-grade inflammation in diabetes promotes the release of inflammatory mediators such as IL-6 and TNF-α, which not only worsen endothelial cell damage but also increase blood vessel permeability and impede angiogenesis (16, 17).